Veradigm (MDRX) has issued an update.
Veradigm Inc. has entered into a Merger Agreement to acquire ScienceIO in a cash transaction valued at $140 million, with certain adjustments and deferred payments. Additionally, Veradigm will grant up to 2.75 million restricted stock units to select ScienceIO employees. Concurrently, Veradigm is facing a potential delisting from Nasdaq due to delayed financial reporting but is working to regain compliance. Moreover, the board has adopted a stockholder rights agreement to deter unwanted takeovers by granting shareholders the right to purchase preferred shares at a discount in the event of significant stock accumulation by an investor, thus protecting shareholder value and company control.
Learn more about MDRX stock on TipRanks’ Stock Analysis page.